arrow
R

Roberto Luzzati

trieste university hospital
H指数:48
被引数:8,182

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Infectious spondylodiscitis: Epidemiology, diagnosis, microbiological findings, clinical features and outcomes in a 14-year retrospective study

感染性脊柱骨髓炎:流行病学、诊断、微生物学发现、临床特征及14年回顾性研究中的结局

2025-09-290
OA
Fever of unknown origin (FUO) FADOI-SIMIT Italian registry: can demographics, comorbidities, and clinical variables predict the etiology of classic FUO?—a prospective Italian study

不明原因发热(Fever of unknown origin, FUO)FADOI-SIMIT意大利注册研究:人口统计学特征、合并症和临床变量能否预测经典FUO的病因?——一项前瞻性意大利研究

2025-08-190
PRE
Real-World Use, Effectiveness, and Safety of Intravenous Fosfomycin: The FORTRESS Study

静脉注射磷霉素的真实世界应用、有效性与安全性:FORTRESS研究

2025-03-191
OA
Fluoroquinolones and Biofilm: A Narrative Review

氟喹诺酮类药物与生物膜:一项叙述性综述

2024-12-113
OAAI
Prediction of 30-day mortality after surgery for infective endocarditis using risk scores: Insights from a European multicenter comparative validation study

使用风险评分预测感染性心内膜炎术后30天死亡率: 来自欧洲多中心比较验证研究的见解

2024-09-012
PRE
Outcomes and Predictors of Mortality in Patients With KPC-Kp Infections Treated With Meropenem Vaborbactam: An Observational Multicenter Study

美罗培南vabobactam治疗kpc-kp感染患者的预后和死亡率预测因素: 一项观察性多中心研究

2024-05-087
OAAI
Human Campylobacter spp. infections in Italy
2024-03-121
PRE
In-label, off-label prescription, efficacy and tolerability of dalbavancin: report from a National Registry
2024-02-075
OAAI
Identification of IncA Plasmid, Harboring blaVIM-1 Gene, in S. enterica Goldcoast ST358 and C. freundii ST62 Isolated in a Hospitalized Patient

鉴定IncA质粒,携带blaVIM-1基因,在S. enterica Goldcoast ST358和C.Freudii ST62中分离出住院患者

2023-11-251
OA
Molnupiravir, Nirmatrelvir/Ritonavir, or Sotrovimab for High-Risk COVID-19 Patients Infected by the Omicron Variant: Hospitalization, Mortality, and Time until Negative Swab Test in Real Life

Molnupiravir,nirmatretvir/Ritonavir或Sotrovimab用于感染Omicron变体的高危新型冠状病毒肺炎患者: 住院,死亡率和实际生活中阴性拭子测试的时间

2023-05-0932
OAAI